<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03126838</url>
  </required_header>
  <id_info>
    <org_study_id>NHIEgypt ,670/2017</org_study_id>
    <nct_id>NCT03126838</nct_id>
  </id_info>
  <brief_title>Diaphragmatic Dysfunction and Cardiac Surgery; Perioperative Assessment and Effect on Outcome</brief_title>
  <official_title>Diaphragmatic Dysfunction and Cardiac Surgery; Perioperative Assessment and Effect on Outcome; Prospective Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Heart Institute, Egypt</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Heart Institute, Egypt</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates incidence of diaphragmatic dysfunction after cardiac surgery and its
      effect on outcome of surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Diaphragmatic dysfunction will be assessed by ultrasonography the day before operation and
      first post operative day, by measuring diaphragmatic thickening during inspiration and
      expiration.incidence of diaphragmatic dysfunction and its effect on outcome of surgery then
      will be analysed.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2017</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Crossover</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diaphragmatic excursion.</measure>
    <time_frame>at the beginning of the spontaneous breathing trial (around 4hours after surgery).</time_frame>
    <description>diaphragmatic excursion (displacement, cm)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>diaphragmatic dysfunction post cardiac surgery.</measure>
    <time_frame>at the beginning of the spontaneous breathing trial (around 4hours after surgery).</time_frame>
    <description>diaphragmatic thickening fraction [Thickness at end inspiration − Thickness at end expiration]
/ Thickness at end expiration</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>. Diaphragmatic excursion</measure>
    <time_frame>the day before surgery</time_frame>
    <description>diaphragmatic excursion (displacement, cm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>• Diaphragm dysfunction before surgery</measure>
    <time_frame>the day before surgery</time_frame>
    <description>diaphragmatic thickening fraction [Thickness at end inspiration − Thickness at end expiration]
/ Thickness at end expiration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Left ventricular ejection fraction</measure>
    <time_frame>the day before surgery</time_frame>
    <description>as indicator of cardiac function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>• Total ventilation time</measure>
    <time_frame>from time of addmission to surgical ICU up to 1 week</time_frame>
    <description>in term of hours (in diaphragmatic dysfunction group)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>• Extracorporeal circulation duration</measure>
    <time_frame>peroperative</time_frame>
    <description>cardiopulmonary bypass time in term of minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>• Ventilation free days.</measure>
    <time_frame>from time of admission to surgical ICU up to 1 week</time_frame>
    <description>after extubation first time tell end of ICU stay, in term of days (in diaphragmatic dysfunction group)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>• Total ICU stay</measure>
    <time_frame>from time of admission to surgical ICU up to 1 week</time_frame>
    <description>in term of days (in diaphragmatic dysfunction group)</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Diaphragm Disease</condition>
  <arm_group>
    <arm_group_label>diaphragmatic dysfunction</arm_group_label>
    <description>diaphragmatic displacement &lt; 10 ml, and / OR diaphragmatic thickening fraction &lt; 36 %.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non diaphragmatic dysfunction</arm_group_label>
    <description>diaphragmatic displacement &gt; 10 ml, and / OR diaphragmatic thickening fraction &gt; 36 %.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        100 adult patients who are ready for elective cardiac surgery.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years old and older

          -  Planned cardiac surgery

          -  Ready for weaning from mechanical ventilation (fraction of inspired oxygen (FIO2) ≤
             50%, positive end-expiratory pressure(PEEP) level≤ 5 centimeter water (cmH2O),
             respiratory rate ≤30 breaths/min, partial pressure of oxygen in arterial
             blood(PaO2)/FIO2 ratio &gt;200 , Glasgow coma score ≥14).

          -  Stable cardiovascular status (i.e., heart rate &lt;120 beats/min; systolic blood
             pressure, 90-160 mmHg; and no or minimal vasopressor use, i.e., dopamine or dobutamine
             ≤5 μg/kg/min or noradrenaline ≤0.05 μg/kg/min).

          -  Stable metabolic status (i.e., electrolytes and glycaemia within normal range, body
             temperature &lt;38 °C, hemoglobinemia ≥8-10 g/dL).

        Exclusion Criteria:

          -  Patients with a history of diaphragmatic or neuromuscular disease or evidence of
             pneumothorax or pneumomediastinum.

          -  Patients with low EF (EF ≤ 30%).

          -  Patients with post-operative cerebrovascular stroke.

          -  Reventilation due to cardiac cause ( arrest, arrhythmias, or failure)

          -  Patient refusal.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>National Heart Institute</name>
      <address>
        <city>Giza</city>
        <state>Embaba</state>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Faten Fa El sayed, MD</last_name>
      <phone>00201005586659</phone>
      <email>Faten-icu@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 11, 2017</study_first_submitted>
  <study_first_submitted_qc>April 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 24, 2017</study_first_posted>
  <last_update_submitted>April 21, 2017</last_update_submitted>
  <last_update_submitted_qc>April 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Heart Institute, Egypt</investigator_affiliation>
    <investigator_full_name>Ibrahim Shawky Morsy Omara</investigator_full_name>
    <investigator_title>32 family housing, area 8, El obour city, Qalubia, Egypt</investigator_title>
  </responsible_party>
  <keyword>diaphragm</keyword>
  <keyword>ultrasound</keyword>
  <keyword>dysfunction</keyword>
  <keyword>cardiac surgery</keyword>
  <keyword>weaning</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

